Edit |   |
---|---|
Antigenic Specificity | CD279, Human (Cemiplimab biosimilar) |
Clone | Cemiplimab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD279 Recombinant Antibody (Cemiplimab). Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer. Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway. |
Immunogen | n/a |
Other Names | Anti-CD279 Recombinant Antibody, Research Grade Cemiplimab, Anti-Human CD279 Recombinant Antibody(Cemiplimab), REGN-2810, SAR-439684, cemiplimab-rwlc, Antibody Drug Analogues, Monoclonal Antibody, YR1516, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1801342-60-8 |
Catalog # | YR1516 |
Price | please inquire |
Order / More Info | CD279, Human (Cemiplimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |